BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 27696432)

  • 1. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
    J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of perioperative inflammatory-based prognostic systems in patients with colorectal liver metastases undergoing surgery. A cohort study.
    Solaini L; Atmaja BT; Arumugam P; Hutchins RR; Abraham AT; Bhattacharya S; Kocher HM
    Int J Surg; 2016 Dec; 36(Pt A):8-12. PubMed ID: 27742565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival.
    Kobayashi T; Teruya M; Kishiki T; Endo D; Takenaka Y; Miki K; Kobayashi K; Morita K
    Dig Surg; 2010; 27(4):285-90. PubMed ID: 20689289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases.
    Nakagawa K; Tanaka K; Nojiri K; Kumamoto T; Takeda K; Ueda M; Endo I
    Ann Surg Oncol; 2014 May; 21(5):1711-8. PubMed ID: 24452408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the C-reactive protein to albumin ratio on long-term outcomes after hepatic resection for colorectal liver metastases.
    Haruki K; Shiba H; Horiuchi T; Sakamoto T; Gocho T; Fujiwara Y; Furukawa K; Misawa T; Yanaga K
    Am J Surg; 2017 Oct; 214(4):752-756. PubMed ID: 28187858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis.
    Okimoto S; Kobayashi T; Tashiro H; Kuroda S; Ishiyama K; Ide K; Abe T; Hashimoto M; Iwako H; Hamaoka M; Honmyo N; Yamaguchi M; Ohdan H
    Int J Surg; 2017 Jun; 42():209-214. PubMed ID: 28483664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Value of Post-operative Serum C-reactive Protein Level for -Survival after Surgery for Colorectal Liver Metastases.
    van der Stok EP; Grünhagen DJ; Rothbarth J; Verhoef C
    Acta Chir Belg; 2015; 115(5):348-55. PubMed ID: 26560001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Significance of C-reactive Protein-To-Lymphocyte Ratio in Colorectal Liver Metastases.
    Taniai T; Haruki K; Hamura R; Fujiwara Y; Furukawa K; Gocho T; Shiba H; Yanaga K
    J Surg Res; 2021 Feb; 258():414-421. PubMed ID: 33109402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    Sasaki K; Andreatos N; Margonis GA; He J; Weiss M; Johnston F; Wolfgang C; Antoniou E; Pikoulis E; Pawlik TM
    J Surg Oncol; 2016 Dec; 114(7):803-809. PubMed ID: 27792291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
    Zeman M; Maciejewski A; Półtorak S; Kryj M
    Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases.
    Neal CP; Mann CD; Garcea G; Briggs CD; Dennison AR; Berry DP
    Arch Surg; 2011 Apr; 146(4):471-8. PubMed ID: 21502458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined evaluation of the Glasgow prognostic score and carcinoembryonic antigen concentration prior to hepatectomy predicts postoperative outcomes in patients with liver metastasis from colorectal cancer.
    Kobayashi T; Kawakamil M; Hara Y; Shioiri S; Yasuno M; Teruya M; Kaminishi M
    Hepatogastroenterology; 2014; 61(133):1359-62. PubMed ID: 25436311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein (CRP) as a prognostic factor for colorectal cancer after surgical resection of pulmonary metastases.
    Li C; Xu Q; Chen L; Luo C; Ying J; Liu J
    Bull Cancer; 2017 Mar; 104(3):232-236. PubMed ID: 28063672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.
    van der Stok EP; Grünhagen DJ; Alberda WJ; Reitsma M; Rothbarth J; Verhoef C
    Dig Surg; 2015; 32(3):208-16. PubMed ID: 25896431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.